The hip joint is one of the body’s largest and most stable joints. It is a ball-and-socket joint, where the rounded head of the femur (thigh bone) fits into the acetabulum (a concave socket in the pelvis). This structure allows for a wide range of motion including walking, bending, and rotating the leg. Cartilage, a smooth and resilient tissue, lines the surfaces of the ball and the socket for smooth movement and shock absorption. Surrounding muscles, tendons, and ligaments support and stabilize the joint.

Hip arthritis occurs when the protective cartilage in the joint begins to break down, leading to inflammation, stiffness, and pain. As cartilage deteriorates, bones can rub directly against each other, resulting in further damage and progressive joint degeneration.

There are several types of arthritis that can affect the hip, with osteoarthritis being the most common. This degenerative form of arthritis is often related to age, wear and tear, or previous joint injuries. Other contributing causes include:

• Rheumatoid arthritis is an autoimmune condition that causes joint inflammation and cartilage damage.
• Post-traumatic arthritis develops after a hip fracture or other injury that disrupts joint structure.
• Avascular necrosis is where reduced blood flow to the femoral head leads to bone tissue death and cartilage loss.
• Developmental disorders such as hip dysplasia, which alter the mechanics of the hip joint and increase arthritis risk.

Symptoms may include persistent groin or thigh pain, stiffness after periods of rest, difficulty walking, or reduced range of motion in the hip. Early identification and treatment are essential to slow progression and maintain joint function.

At Vitality Orthopedics and Biologics, our initial approach to hip arthritis is typically non-surgical and personalized to each patient’s condition, goals, and lifestyle. Conservative measures may include:

• Activity modification to reduce joint stress
• Physical therapy to improve flexibility, strength, and gait mechanics
• Weight management to reduce load on the hip joint
• Anti-inflammatory medications or topical pain relievers for symptom control
• Assistive devices such as a cane or walker to help offload the affected joint

When conventional methods are not enough, regenerative therapies may offer additional relief and help promote healing of the joint tissue.

Regenerative medicine is an evolving field that focuses on enhancing the body’s natural ability to repair and restore damaged tissues. These therapies can be particularly effective in managing early to moderate stages of hip arthritis by reducing inflammation, improving joint lubrication, and stimulating tissue regeneration.

• Red light therapy uses low-level wavelengths of light to penetrate soft tissues, reduce inflammation, and stimulate cellular repair. It is a non-invasive option that may help relieve pain and improve circulation around the hip joint, especially when used in combination with other therapies.
• Laser therapy, specifically Class IV therapeutic laser, delivers concentrated light energy to deeper tissues to reduce inflammation, promote blood flow, and support tissue healing. This modality may be helpful for patients experiencing chronic hip pain and stiffness.
• Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized environment, which enhances oxygen delivery to tissues and may reduce inflammation and promote the healing of soft tissue and bone. HBOT has shown promise in managing chronic joint pain and may be particularly beneficial for patients with avascular necrosis contributing to hip arthritis.
• Platelet-rich plasma (PRP) therapy involves drawing a small amount of a patient’s blood, processing it to concentrate the platelets, and injecting it into the affected hip joint. Platelets contain growth factors that can reduce inflammation and stimulate healing of cartilage and surrounding tissues. PRP is widely used in orthopedic settings as a minimally invasive option for joint preservation.
• Bone marrow aspirate concentrate (BMAC) uses stem cells and other regenerative components from a patient’s bone marrow. These cells are injected into the joint to help reduce pain and support cartilage repair. BMAC may be a promising option for patients who are not ready for joint replacement but are experiencing significant functional decline.
• BPC-157 peptide therapy is an emerging treatment that uses a synthetic peptide derived from a natural gastric protein. It is believed to support tissue repair and reduce inflammation. When used in conjunction with other therapies, BPC-157 may accelerate healing of joint tissues and improve outcomes in patients with chronic arthritis.